Intellectual Property India Publishes Patent Application for 'Aav Vectors Encoding Oxidoreductase Enzyme And Uses Thereof' Filed by Oyster Point Pharma Inc.

MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517035118 A) filed by Oyster Point Pharma Inc., Princeton, U.S.A., on April 10, for 'aav vectors encoding oxidoreductase enzyme and uses thereof.'

Inventor(s) include Carlson Eric C; and Nau Jeffrey Alan.

The application for the patent was published on May 2, under issue no. 18/2025.

According to the abstract released by the Intellectual Property India: "Provided are recombinant adeno associated virus (rAAV) vectors methods of treating an ocular condition pharmaceutical compositions and other compositions and methods in which the rAAV vector comprises a polynucleotide encoding oxidoreductase enzymes. Methods of treatment may include administration ...